GREENLEAF PETER (Chief Executive Officer) received a stock award from AURINIA PHARMACEUTICALS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/5/2026ACC: 0001600620-26-000002
DirectorOfficer· Chief Executive Officer
Since Jan 2021
+52.22K
Net shares
Net buyer
$1.81M
Total sold
0
Open market trades
0B · 0S
2
Total transactions
165.38K acquired · 113.17K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+165.38K
Price / share
—
Trade value
—
% of position
9.2%
1/2/2026
1.79M→1.95M
Common Stock
Direct
Shares
−113.17K
Price / share
$15.95
Trade value
$1.81M
% of position
5.8%
1/2/2026
1.96M→1.85M
Total
Net shares
+52.22K
Net value
-$1.81M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | A · Award | +165.38K | — | — | 9.2% | 1.79M | 1.95M |
| Common Stock Direct | 1/2/2026 | F · Tax Withholding | −113.17K | $15.95 | $1.81M | 5.8% | 1.96M | 1.85M |
| Total | +52.22K | -$1.81M | ||||||
Derivative Transactions0
No derivative transactions reported